Literature DB >> 21594705

Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva.

Linn Woelber1, Matthias Choschzick, Christine Eulenburg, Matthaeus Hager, Fritz Jaenicke, Friederike Gieseking, Lilli Kock, Maike Ihnen, Cordula Petersen, Joerg Schwarz, Sven Mahner.   

Abstract

BACKGROUND: A tumor-free resection margin of at least 8 mm is considered state of the art in vulvar cancer. This standard is based on small and heterogeneous patient cohorts, and its implementation can result in mutilation.
METHODS: One hundred two consecutive patients with primary squamous cell vulvar cancer were analyzed. All patients received resection of the primary tumor and the inguinofemoral lymph nodes via three separate incisions, resulting in complete tumor resection. Median follow-up was 31 months. Minimal margin distances were pathologically determined in all dimensions after fixation.
RESULTS: Median age of the patients was 62 years; 38.2% had International Federation of Gynecology and Obstetrics (FIGO) stage I, 17.6% stage II, 24.4% stage III, and 8.8% stage IV disease. The median minimal resection margin was 5 mm (range 0.5-25 mm). Sixteen patients (15.6%) developed disease recurrence, of whom 10 (62.5%) at the vulva. Margin distance had no significant impact on disease-free survival when analyzed continuously (p = 0.388). When cases were divided into three subgroups of <3 mm (28.4%), ≥3 to <8 mm (42.2%), and ≥8 mm (29.4%) resection margin, neither univariate nor multivariate analysis revealed a difference in disease-free survival. There was no significant difference between any of the subgroups regarding tumor stages and adjuvant radiotherapy of the vulva. These results were independent of the direction of the minimal margin distance and consistent when only vulvar recurrences were analyzed.
CONCLUSIONS: A tumor-free resection margin is essential for locoregional control in vulvar cancer. However, in this large, single-center study, we could not demonstrate any prognostic impact of pathological margin distance.

Entities:  

Mesh:

Year:  2011        PMID: 21594705     DOI: 10.1245/s10434-011-1778-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

2.  Abdominoperineal Excisions in the Treatment Regimen for Advanced and Recurrent Vulvar Cancers-Analysis of a Single-Centre Experience.

Authors:  Sabine Hannes; Johanna M Nijboer; Alexander Reinisch; Wolf O Bechstein; Nils Habbe
Journal:  Indian J Surg       Date:  2015-04-24       Impact factor: 0.656

3.  Optimal cone size to predict positive surgical margins after cold knife conization (CKC) and the risk factors for residual disease.

Authors:  Murat Öz; Nilüfer Çetinkaya; Elmas Korkmaz; Kerem Doğa Seçkin; Mehmet Mutlu Meydanlı; Tayfun Güngör
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

4.  Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins.

Authors:  Tanja Ignatov; Holm Eggemann; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-02       Impact factor: 4.553

5.  Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.

Authors:  Leonardo Micheletti; Mario Preti; Viviana Cintolesi; Elisabetta Corvetto; Silvana Privitera; Eleonora Palmese; Chiara Benedetto
Journal:  J Gynecol Oncol       Date:  2018-04-13       Impact factor: 4.401

Review 6.  The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer.

Authors:  Andrea Giannini; Ottavia D'Oria; Benito Chiofalo; Valentina Bruno; Ermelinda Baiocco; Emanuela Mancini; Rosanna Mancari; Cristina Vincenzoni; Giuseppe Cutillo; Enrico Vizza
Journal:  J Obstet Gynaecol Res       Date:  2021-12-28       Impact factor: 1.697

Review 7.  Management of Early-Stage Vulvar Cancer.

Authors:  Priscila Grecca Pedrão; Yasmin Medeiros Guimarães; Luani Rezende Godoy; Júlio César Possati-Resende; Adriane Cristina Bovo; Carlos Eduardo Mattos Cunha Andrade; Adhemar Longatto-Filho; Ricardo Dos Reis
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

8.  Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva.

Authors:  Sara Iacoponi; Ignacio Zapardiel; Maria Dolores Diestro; Alicia Hernandez; Javier De Santiago
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

Review 9.  Vulvar carcinoma: dilemma, debates, and decisions.

Authors:  Swarupa Mitra; Manoj Kumar Sharma; Inderjeet Kaur; Ruparna Khurana; Kanika Batra Modi; Raman Narang; Avik Mandal; Soumya Dutta
Journal:  Cancer Manag Res       Date:  2018-01-09       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.